key: cord-1025225-02wj2li3 authors: Fajardo, Álvaro; Perbolianachis, Paula; Ferreiro, Irene; Moreno, Pilar; Moratorio, Gonzalo title: Molecular Accuracy vs Antigenic Speed: SARS-CoV-2 Testing Strategies date: 2021-12-21 journal: Curr Opin Pharmacol DOI: 10.1016/j.coph.2021.12.006 sha: e4ad023753a16dde8b6270604db2c677bb2a881b doc_id: 1025225 cord_uid: 02wj2li3 The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit every corner of the world faster than any infectious disease ever known. In this context, rapid and accurate testing of positive cases are essential to follow the test-trace-isolate strategy (TETRIS), which has proven to be a key approach to constrain viral spread. Here, we discuss how to interpret and combine molecular or/and antigen-based detection methods for SARS-CoV-2 as well as when they should be used. Their application can be cleverly designed as an algorithm to prevent viral dissemination according to distinct epidemiological contexts within surveillance programs. suggested as suitable alternatives [35] , although further studies are needed to evaluate their 126 performances [36] [37] [38] . In COVID-19 hospitalized patients with lower respiratory tract diseases, 127 endotracheal aspirates, bronchoalveolar lavage fluid, and sputum may be considered and have 128 even shown greater persistence of the SARS-CoV-2 viral load compared to samples from the 129 upper respiratory tract [39, 40] . 130 The median incubation period (the time elapsed from the infection with SARS-CoV-2 and the 131 onset of symptoms) is around 5-7 days [41] [42] [43] [44] . This period corresponds to the time when viral 132 load peaks, both for symptomatic and asymptomatic individuals ( Figure 1 ) [45, 46] . Therefore, 133 both molecular and antigenic tests will have a better performance with sampling times at the 134 beginning of symptoms or around day 5-7 after infection ( Figure 1 ). 135 Testing strategies should be dynamic and adaptable to evolving epidemiological scenarios. Thus, 136 detection methods of choice must rely on several factors that should be specifically weighed in 137 order to implement effective approaches to constrain the dissemination of SARS-CoV-2. On the 138 basis of the CDC metrics, the level of community transmission can be considered low when the 139 percentage of positive SARS-CoV-2 diagnostic nucleic acid amplification tests in the last 7 days 140 is below 5% [47] . In a community with low viral circulation, priority should be given to detect 141 the largest number of positive cases, including patients with low viral loads who may be 142 asymptomatic or pre-symptomatic. Several studies have evidenced culturable viruses in patients 143 with significantly low viral loads [20, 48, 49] . Moreover, asymptomatic and pre-symptomatic 144 transmissions have been extensively reported [50] [51] [52] [53] [54] . Thus, in these epidemiological contexts, 145 highly sensitive detection methods as molecular-based techniques must be used to quarantine 146 positive individuals before they increase their contagiousness. By these means, false-negative 147 results are limited, which may arise when using low-sensitivity diagnostic tools. In addition, as 148 long as the prevalence remains low, sample-pooling strategies can be effectively applied to should be noted that, as stated before, although infectious viruses are rarely recovered in viral 151 culture after 10 days of symptoms, prolonged viral RNA shedding has been evidenced in upper must emphasize that a positive result by rtRT-PCR should not be considered as an indicator of 154 active infection, but should be associated with available data about the onset and duration of 155 symptoms to evaluate the likelihood of transmission of the infected individual. A different scenario occurs in high prevalence settings where the use of highly sensitive 157 diagnostic techniques becomes a second order of priority, prevailing the strategies that allow 158 large populations screening in short turn-around times [14] . In these epidemiological contexts, 159 the focus should be put on the rapid detection and isolation of people with high viral loads, as 160 they may act as super spreaders [58, 59] . Highly contagious individuals have proven to shape the 161 course of the pandemic, being the major drivers of viral transmission [58, 59] . Consequently, 162 under these circumstances, antigen-based methods should be implemented as they can reliably A new coronavirus associated with human respiratory disease in China The challenges of containing SARS-CoV-2 204 via test-trace-and-isolate An effective COVID-19 207 response in South America: the Uruguayan Conundrum. medRxiv 2020 Phylogenetic analysis of SARS-192 CoV-2 in Boston highlights the impact of superspreading events Reinfection With SARS-CoV-2: Implications for Vaccines Team CC-19 VBCI, Team CC-19 VBCI, Team CC-19 VBCI Breakthrough Infections Reported to CDC -United States African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant Confirmed Reinfection With Severe Acute Respiratory Syndrome 205 Coronavirus 2 (SARS-CoV-2) Variant VOC-202012/01 SARS-CoV-2 Reinfection Involving E484K Spike Mutation Number 5-May 2021 -Emerging Infectious Diseases journal -CDC. Emerg Infect 211 Dis 2021 Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil Rumm after six months: a longitudinal prospective study Safety and Efficacy of the BNT162b2 mRNA 222 Covid-19 Vaccine through 6 Months This study indicate that BNT162b2 vaccine prevents COVID-19 for up to 6 months, despite 225 the emergence of SARS-CoV-2 variants COVID vaccine immunity is waning -how much does that matter? Initial report of decreased SARS-CoV-2 viral load after 230 inoculation with the BNT162b2 vaccine Covid-19 with the BNT162b2 and mRNA-1273 Vaccines J o u r n a l P r e -p r o o f